{# Audit 04/10/2026 : « autre » n'est pas un code de langue ; SPHAERO n'est pas l'éditeur des documents qu'elle héberge ou référence. #} {# citation_pdf_url doit mener à un PDF : un lien vers une page DOI est pénalisé par Google Scholar (avant : tout lien externe). #}
Accès ouvert · CC BY

APOE E4 is associated with impaired self-declared cognition but not disease risk or age of onset in Nigerians with Parkinson’s disease

Article scientifique 2022 Anglais

Résumé

The relationship between APOE polymorphisms and Parkinson's disease (PD) in black Africans has not been previously investigated. We evaluated the association between APOE polymorphic variability and self-declared cognition in 1100 Nigerians with PD and 1097 age-matched healthy controls. Cognition in PD was assessed using the single item cognition question (item 1.1) of the MDS-UPDRS. APOE genotype and allele frequencies did not differ between PD and controls (p > 0.05). No allelic or genotypic association was observed between APOE and age at onset of PD. In PD, APOE ε4/ε4 conferred a two-fold risk of cognitive impairment compared to one or no ε4 (HR: 2.09 (95% CI: 1.13-3.89; p = 0.02)), while APOE ε2 was associated with modest protection against cognitive impairment (HR: 0.41 (95% CI 0.19-0.99, p = 0.02)). Of 773 PD with motor phenotype and APOE characterized, tremor-dominant (TD) phenotype predominated significantly in ε2 carriers (87/135, 64.4%) compared to 22.2% in persons with postural instability/gait difficulty (PIGD) (30/135) and 13.3% in indeterminate (ID) (18/135, 13.3%) (p = 0.037). Although the frequency of the TD phenotype was highest in homozygous ε2 carriers (85.7%), the distribution of motor phenotypes across the six genotypes did not differ significantly (p = 0.18). Altogether, our findings support previous studies in other ethnicities, implying a role for APOE ε4 and ε2 as risk and protective factors, respectively, for cognitive impairment in PD.

Citer ce document

Okubadejo, N., Okunoye, O., Ojo, O. O., Arabambi, B., Akinyemi, R., Osaigbovo, G., Abubakar, S., Iwuozo, E., Wahab, K., Agabi, O., Agulanna, U., Imarhiagbe, F., Abiodun, O., Achoru, C., Adebowale, A., Adeniji, O., Akpekpe, J. E., Ali, M., Ani‐Osheku, I., Arigbodi, O., Balarabe, S. A., Bello, A., Ekenze, O., Erameh, C., Farombi, T., Fawale, B., Komolafe, M., Nwani, P., Nwazor, E., Nyandaiti, Y., Obehighe, E. E., Obiabo, Y., Odeniyi, O., Odiase, F., Ojini, F., Onwuegbuzie, G., Osemwegie, N., Oshinaike, O., Otubogun, F., Oyakhire, S., Taiwo, F., Williams, U., Ozomma, S., Zubair, Y., Hernández, D., Bandrés‐Ciga, S., Blauwendraat, C., Singleton, A., Houlden, H., Hardy, J., & Rizig, M. (2022). APOE E4 is associated with impaired self-declared cognition but not disease risk or age of onset in Nigerians with Parkinson’s disease. npj Parkinson s Disease. https://doi.org/10.1038/s41531-022-00411-x

Exporter : BibTeX · RIS (Zotero, Mendeley, EndNote)

Accès au document

Texte intégral en lecture en ligne, réservé aux abonnés SPHAERO et aux membres de l'institution. Se connecter

Voir l'article sur le site de la revue

Licence et provenance

Licence : CC BY

Notice moissonnée depuis OpenAlex le 10/09/2026. Le document reste hébergé par sa source.
Voir le document à la source →

Statistiques

Consultations : 4

Téléchargements : 0